Puestos
20✅ EPS: $6.03 adj. vs. $4.94 est.
✅ Revenue: $50.1B vs. $49.5B est. (+12% Y/Y)
• Operating margin: 2.6% (↓ from 3.1% Y/Y)
• Reaffirmed FY25 EPS guidance of ~$30 and benefit expense ratio ~90%
• Returned $3.3B to shareholders YTD
📊 Takeaway: Elevance Health delivered a clear earnings beat with strong revenue growth and disciplined execution. Margins remain under pressure, but reaffirmed guidance and solid cash returns highlight operational strength heading into 2026.
$UNH (+0,63 %)
$BRK.B (-0,13 %)
$BRK.A (+0 %)
Buffett has probably bought far more than the stated 5 million shares of $UNH (+0,63 %) probably much more.
This can be concluded from the fact that Berkshire Hathaway no longer requires a confidentiality note for the current quarter.
Today's 13F only covers transactions through June 30, we don't know how much he bought after that.
The closing price on this day for $UNH (+0,63 %) was $311.97.
In between there are another 45 days where the price has mostly fallen further.
Therefore, confidential treatment of $BRK.B (-0,13 %) is no longer necessary.
We will find out exactly how much he has collected in 3 months, but I believe that he was not satisfied with the initial purchase with the share price continuing to fall and so much cash on hand 💪
Other buyers:
$CNC (+1,17 %)
$OSCR (+13,09 %)
$CVS (+0,85 %)
$CI (+0,59 %)
$ELV (-0,51 %)
+ 1
$UNH (+0,63 %)
$CNC (+1,17 %)
$US60855R1005 (+0,01 %)
$ELV (-0,51 %)
$CVS (+0,85 %)
How the loss of $CNC (+1,17 %) and $US60855R1005 (+0,01 %) shows, Medicaid is charity care because you lose money when you care for the sickest and poorest population. To make a profit, you want as few Medicaid patients as possible.
$UNH (+0,63 %) is in a better position ✌️
Next sale in the health insurance sector ?
🔹 Revenue: USD 48.74 billion (estimated USD 44.24 billion) ✅
🔹 Adjusted earnings per share: ( USD 0.16) (estimated USD 0.23) ❌
🔹 Health insurance ratio: 93.0% (estimated 91.6%) ❌ ; increase of +5.4 percentage points compared to the previous year
🔹 Total income from premiums and services: USD 42.47 billion; increase of 18% compared to the previous year
🔹 Selling and administrative expenses ratio: 7.1 %
Segment revenue:
🔹 Medicaid: USD 21.72 billion; increase of 7% compared to the previous year
Commercial: USD 10.07 billion; increase of 18% compared to the previous year
🔹 Medicare: USD 9.45 billion; increase of 58% compared to the previous year
🔹 Other: USD 1.22 billion; increase of 1% compared to the previous year
Other metrics
🔹 Cash flow from operating activities: USD 1.79 billion
🔹 Payability days for claims: 47 days
CEO comment:
➡️ "We are disappointed with our second quarter results, but have a clear understanding of the trends that impacted our performance and are working diligently and with focus to restore our earnings performance." - Sarah M. London
➡️ "Despite the changing landscape, we believe the staying power of Medicaid, Medicare and the Individual Marketplace is stronger than ever." - Sarah M. London
$UNH (+0,63 %)
$US60855R1005 (+0,01 %)
$CVS (+0,85 %)
$CI (+0,59 %)
$XDWH (+0,76 %)
$XDWH (+0,76 %)
$XLV (+0,65 %)
$CSPX (+0,17 %)
$VUSA (+0,24 %)
$UNH (+0,63 %)
$OSCR (+13,09 %)
According to Goldman Sachs, healthcare is the only sector in the S& P 500 that is cheaper than the 10- and 30-year averages.
This is an extremely attractive risk/reward ratio and the coming months will be exciting.
$ELV (-0,51 %)
$CNC (+1,17 %)
$DHR (+7,84 %)
$SRT (+1,69 %)
$LLY (-0,66 %)
$NOVO B (-1,42 %)
$NVO (-1,46 %)
$ISRG (+17,99 %)
$JNJ (-0,14 %)
$ABBV (-0,4 %)
$PFE (+0,9 %)
$SAN (+0,22 %)
$MRK (+1,48 %)
$BMY (+1,86 %)
$TMO (+2,73 %)
$UNH (+0,63 %)
$OSCR (+13,09 %)
$XDWH (+0,76 %)
$ELV (-0,51 %)
$LLY (-0,66 %)
$XLV (+0,65 %)
The US healthcare sector is experiencing its biggest crash in the last 20 years.
If the strong weighting no. 1 $LLY (-0,66 %) (over 12%), one would have to go back even further/longer. (probably before the existence of the ETF).
I have positioned myself strongly here as I believe this is a great opportunity.
I also believe that a lot of capital will flow into the sector in the coming months. ✌️
Do you have a similar view? ✌️
$UNH (+0,63 %)
$OSCR (+13,09 %)
$XDWH (+0,76 %)
$ELV (-0,51 %)
$LLY (-0,66 %)
$XLV (+0,65 %)
The US healthcare sector is experiencing its biggest crash in the last 20 years.
If the strong weighting no. 1 $LLY (-0,66 %) (over 12%), one would have to go back even further/longer. (probably before the existence of the ETF).
I have positioned myself strongly here as I believe this is a great opportunity.
I also believe that a lot of capital will flow into the sector in the coming months. ✌️
Do you have a similar view? ✌️
The second-largest health insurer reported its profits. Although these were below consensus, they were not too bad given the panic in the industry.
The benefit cost ratio was 88.9%, an increase of 260 basis points from the previous year, reflecting the trend toward higher medical costs, particularly in the Medicaid business and ACA health plans.
CEO Comment:
$UNH (+0,63 %)
$CNC (+1,17 %)
$US60855R1005 (+0,01 %)
$CVS (+0,85 %)
$OSCR (+13,09 %)
$UNH (+0,63 %) has not experienced two consecutive years of negative returns since 1987.
Who is still invested here, who is buying, what are your assessments? 🤔
In my opinion, a lot of negative things are already priced in here.
yes, of course there is still downside potential, but the risk/reward ratio is already very attractive
The entire sector has similar ways of working and a decline/reduction in Medicare could $UNH (+0,63 %) as the top dog in the private sector could even play into its hands.
UnitedHealth Group $UNH (+0,63 %) has traded at the largest deviation from the S&P 500 price-to-earnings ratio since its IPO ...
This stock has literally NEVER been this cheap relative to the S&P 500.
Incredibly exciting to follow the story.
$CNC (+1,17 %)
$CVS (+0,85 %)
$OSCR (+13,09 %)
$HUM (-1,79 %)
$CI (+0,59 %)
$ELV (-0,51 %)
$XDWH (+0,76 %)
🔹 Adj EPS: $8.84 (Est. $9.07) 🔴
🔹 Revenue: $49.4 B (Est. $48.14B) 🟢; +14.3% YoY
FY25 Guidance
🔹Adj EPS: $30.00 (Est. $34.48) 🔴
Q2 Segment / Product Results
🔹 Health Benefits revenue: $41.6 B; UP +12% YoY
🔹 Health Benefits operating margin: 3.8%; DOWN –200 bp YoY
🔹 Carelon revenue: $18.1 B; UP +36% YoY
🔹 Carelon adjusted operating margin: 5.2%; DOWN –40 bp YoY
Other Metrics
🔹 Benefit expense ratio: 88.9%; UP +260 bp YoY
🔹 Operating expense ratio: 10.1%; DOWN –160 bp YoY
🔹 Returned $2.0 B capital to shareholders YTD
CEO Commentary
🔸 “In the second quarter, Elevance Health made meaningful progress in delivering an experience that is simple and personal to those we serve, while advancing our efforts to enhance efficiency across the healthcare system… With the embedded earnings power of our diversified Health Benefits and Carelon businesses, we remain confident in achieving at least 12% average annual growth in adjusted diluted EPS over time.” – Gail K. Boudreaux
$UNH (+0,63 %) has not experienced two consecutive years of negative returns since 1987.
Who is still invested here, who is buying, what are your assessments? 🤔
In my opinion, a lot of negative things are already priced in here.
yes, of course there is still downside potential, but the risk/reward ratio is already very attractive
The entire sector has similar ways of working and a decline/reduction in Medicare could $UNH (+0,63 %) as the top dog in the private sector could even play into its hands.
UnitedHealth Group $UNH (+0,63 %) has traded at the largest deviation from the S&P 500 price-to-earnings ratio since its IPO ...
This stock has literally NEVER been this cheap relative to the S&P 500.
Incredibly exciting to follow the story.
$CNC (+1,17 %)
$CVS (+0,85 %)
$OSCR (+13,09 %)
$HUM (-1,79 %)
$CI (+0,59 %)
$ELV (-0,51 %)
$XDWH (+0,76 %)
Molina $US60855R1005 (+0,01 %) - 80 %
Centene $CNC (+1,17 %) - 52 %
Elevance $ELV (-0,51 %) - 25 %
UnitedHealth $UNH (+0,63 %) - 11 %
CVS Health (Aetna) $CVS (+0,85 %) - 6 %
Companies that in my opinion have upside potential on positive news.
Healthcare sector in general with a lot of catch-up potential, can in my opinion be well overplayed. $XDWH (+0,76 %) play.
Do you have any sectors that you play via ETFs and if so, which ones?
I would be interested, I will probably now also set up a savings plan on $DAPP (-2,36 %) and make a first purchase.
In my opinion, this should $BTC (-2,3 %) and a large part of the associated companies.
(Even if we are already somewhat further advanced)
Looking forward to your opinions and sector ETF's, even if they are only short term positions.
Normally I only go for individual stocks, but as I hardly want to hold cash, I feel very comfortable in the healthcare sector at the moment. ✌️
19 purchases in 2025, some already in the red
$CVS (+0,85 %)
$OSCR (+13,09 %)
$CI (+0,59 %)
$HUM (-1,79 %)
$CNC (+1,17 %)
$ELV (-0,51 %)
Supplementary information/further research:
ESPP programs have a contribution limit of $25,000 per year per employee under IRS 423c. You cannot buy unlimited shares. This buying pressure is negligible for price movements (especially long term).
In addition, the buying power is split between two purchase dates.
The participation rate of $UNH (+0,63 %) employees in the ESPP is unlikely to be anywhere near 100% and some employees will often sell their shares on the same day they buy them as there is no holding period.
Here are more insights from Mr. Peter Ottavio on UNH/Optum Rx and Optum Health:
(For those who are interested)
These are just a few of the many reasons why I love working at this company as a partner/physician of OptumHealth/UHG. UNH functions more like three efficient companies in one.
OptumHealth is a subsidiary of UnitedHealth Group and focuses on healthcare delivery, population health management and technology-enabled services. With approximately 90,000 physicians and 40,000 healthcare providers, it is the largest provider network in the country. This size provides providers with the resources they need to care for patients efficiently and effectively. Of all the health systems I've worked for, I've never had the resources to care for a sick patient so effectively. In addition, I have never experienced such tremendous growth of a provider network during my three years here.
If a patient comes to me with a cough, I can immediately have x-rays and blood work done in the same building without authorization or delay. The patient then comes back into the hallway to review the images and discuss the next steps in treatment. In the unlikely event that a lung tumor is detected, I can have a CT scan of the chest performed immediately on campus (or off campus if the patient wishes) on the same day and come back the same day to discuss the next steps. If a PET scan is then required, I can have this done as soon as possible. I can honestly say that I have never been refused a CT or PET scan for valid reasons.
OptumRx is the pharmacy benefit management and pharmacy supply arm of UnitedHealth Group and is one of the largest mail-order pharmacies in the country. OptumRx often provides necessary medications affordably and efficiently. The choice is up to the patient, but for long-term therapy, many choose this route.
The sad news about Brian Thompson has hit us hard. While I have heard many good things about him, the role of the insurance arm of the company is not one of my responsibilities.
I have watched countless hours of interviews and presentations by Hemsley and would liken him to Steve Jobs as the true expert on these companies and would definitely welcome him back.
Regarding ESPP.
UnitedHealth Group's Employee Stock Purchase Plan (ESPP) allows eligible employees of UnitedHealth Group (UHG), including its subsidiaries such as UnitedHealthcare, to purchase UHG common stock (traded under the symbol UNH) at a discounted price through payroll deductions. Employees who elect to do so will receive six months of regular payroll deductions from January 2 through July 1 and from July 2 through January 1. These payroll deductions are accumulated in an escrow account and purchased on July 1 at a discounted rate at the same time. Our portfolio books the purchase on the following day.
None of this is financial advice, but for those of you who have requested information on the role of UHG companies and their ESPP, this is the well-documented and non-confidential information provided.
Principales creadores de la semana
